Share chart Cullinan Oncology, Inc.
Extended chart
Simple chart
About Cullinan Oncology, Inc.
Cullinan Management, Inc., биофармацевтическая компания, специализируется на разработке целого ряда целевых онкологических и иммуноонкологических методов лечения онкологических больных в США. Ведущим кандидатом компании является CLN-081, небольшая молекула, доступная для перорального применения, которая проходит фазу I / IIa испытаний по увеличению и увеличению дозы для лечения пациентов с немелкоклеточным раком легкого. more detailsIPO date | 2021-01-08 |
---|---|
ISIN | US2300311063 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.cullinanoncology.com |
Цена ао | 7.91 |
Change price per day: | -3.67% (7.91) |
---|---|
Change price per week: | -1.04% (7.7) |
Change price per month: | -1.55% (7.74) |
Change price per 3 month: | -22.95% (9.89) |
Change price per half year: | -50.2% (15.3) |
Change price per year: | -71.48% (26.72) |
Change price per 3 year: | -33.62% (11.48) |
Change price per year to date: | -36.61% (12.02) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
MPM BioImpact Capital LLC | 8 | 13.27 |
BVF Inc. | 3 | 5.55 |
Blue Owl Capital Holdings LP | 3 | 5.07 |
Franklin Resources, Inc. | 3 | 4.68 |
Blackrock Inc. | 2 | 4.21 |
Vanguard Group Inc | 2 | 3.08 |
State Street Corporation | 1 | 2.47 |
Paradigm Biocapital Advisors LP | 1 | 2.34 |
Braidwell LP | 1 | 2.15 |
Nextech Invest Ag | 1 | 2.12 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Future Tech ETF | 0.10146 | 426.34 | 0.8416 |
Principal Healthcare Innovators ETF | 0.10146 | 618.5 | 0.8416 |
iShares Morningstar Small-Cap Value ETF | 0.02135 | -3.08 | 2.50476 |
iShares Morningstar Small-Cap ETF | 0.01513 | 391.25 | 1.60498 |
iShares Morningstar Small-Cap Growth ETF | 0.01056 | 3.67 | 0.72598 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Patrick A. Baeuerle Ph.D. | Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board | 763.73k | 1958 (67 years) |
Dr. Jennifer Michaelson Ph.D. | Chief Scientific Officer | N/A | 1967 (58 years) |
Mr. Nadim Ahmed | President, CEO & Director | 1.16M | 1968 (57 years) |
Ms. Rose Weldon | Senior Vice President of Communications | N/A | |
Mr. Steve Andre | Chief Human Resources Officer | N/A | |
Dr. Corinne Savill Ph.D. | Chief Business Officer | N/A | 1959 (66 years) |
Dr. Jeffrey Jones M.B.A., M.D., M.P.H. | Chief Medical Officer | 780.32k | 1971 (54 years) |
Ms. Jacquelyn L. Sumer J.D. | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | N/A | 1978 (47 years) |
Mr. Kevin A. Johnston | Chief Technical Operations Officer | N/A | |
Ms. Mary Kay Fenton | Chief Financial Officer | 1964 (61 year) |
Address: United States, Cambridge, One Main Street - open in Google maps, open in Yandex maps
Website: http://www.cullinanoncology.com
Website: http://www.cullinanoncology.com